Platelet aggregation-IN-3

• Target :

  Histamine Receptor|||5-HT Receptor|||Adrenergic Receptor

• Related Pathways :

  Neuroscience|||GPCR/G Protein|||Immunology/Inflammation

• Bioactivity :

  Platelet aggregation-IN-3 (Compound 5) acts as a ligand for H2 histamine receptors, ?2 (A, C) -adrenergic receptors (?2-AR), and 5-HT2 (B, C) serotonin receptors. This compound can inhibit platelet aggregation induced by ADP and collagen, and it also modulates tumor cell-induced platelet aggregation (TCIPA) . Platelet aggregation-IN-3 is a promising candidate for anti-platelet therapy in cardiovascular disease and the prevention of cancer-associated thrombosis and tumor metastasis.

• Smiles :

  Cl.N1=C(NC2=CC=C3C(=C2)CCCC3)NCC1

• Molecular Formula :

  C13H18ClN3

• Molecular Weight :

  251.755

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  1029802-21-8